On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: An immunochemical perspective

Clinical and Experimental Allergy

Volumn 39, Issue 3, 2009, Pages 325-344

  Baldo, B A ^a   Fisher, M M ^a   Pham, N H ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCURONIUM; AMMONIA; CHOLINE; CODEINE; DECAMETHONIUM; GALLAMINE; IMMUNOGLOBULIN E ANTIBODY; MORPHINE; MORPHINE DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; PHOLCODINE; PHOSPHORYLCHOLINE; ROCURONIUM; SUXAMETHONIUM; TUBOCURARINE CHLORIDE; VECURONIUM;

ALLERGY; ANAPHYLAXIS; ANTIBODY SPECIFICITY; ANTIGEN BINDING; CROSS REACTION; DIAGNOSTIC TEST; DRUG HYPERSENSITIVITY; DRUG PROTEIN BINDING; DRUG STRUCTURE; HUMAN; IMMUNOASSAY; IMMUNOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCANDINAVIA; SENSITIZATION; STRUCTURE ACTIVITY RELATION;

ANAPHYLAXIS; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; CROSS REACTIONS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MORPHINE DERIVATIVES; NEUROMUSCULAR BLOCKING AGENTS; QUATERNARY AMMONIUM COMPOUNDS;

EID: 58849157667     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2008.03171.x     Document Type: Review

References (77)

1. Levine BB. Immunochemical mechanisms of drug allergy. In : Miescher PA, Muller-Eberhard HJ, eds. Textbook of immunopathology, Vol. 1. New York : Grune and Stratton, 1976 403 20.
2. Dewdney JM. Immunobiology of the antibiotics. In : Sela M, ed. The antigens, Vol. 4. New York : Academic Press, 1977 73 228.
3. De Weck AL. Penicillins and cephalosporins. In : de Weck AL, Bundgaard H, eds. Allergic reactions to drugs. Handbook of experimental pharmacology, Vol. 63. Berlin : Springer, 1983 423 82.
4. Baldo BA. Diagnosis of allergy to penicillins and cephalosporins. Structural and immunochemical considerations. Allergy Clin Immunol Int 2000 12 : 206 12.
5. MacIntosh RR. Deaths under anaesthetics. Br J Anaesth 1948 21 : 107 36.
6. Anonymous. Special committee investigating deaths under anaesthesia. Report on 745 classified cases, 1960-1968. Med J Aust 1970 1 : 573 94.
7. Jerums G, Whittingham S, Wilson P. Anaphylaxis to suxamethonium. Br J Anaesth 1967 39 : 73 6.
8. Vervloet D, Arnaud A, Vellieux P, Kaplanski S, Charpin J. Anaphylactic reactions to muscle relaxants under general anaesthesia. J Allergy Clin Immunol 1979 63 : 348 53.
9. Fisher MM, More DG. The epidemiology and clinical features of anaphylactic reactions in anaesthesia. Anaesth Intens Care 1981 9 : 226 34.
10. Moneret-Vautrin DA, Laxenaire MC, Moeller R. Anaphylaxis due to succinylcholine. Immunoallergological study of thirteen cases. Clin Allergy 1981 11 : 175 83.
11. Fisher MM, Munro I. Life-threatening anaphylactoid reactions to muscle relaxants. Anesth Analg 1983 62 : 559 64.
12. Baldo BA, Fisher MM. Substituted ammonium ions as allergenic determinants in drug allergy. Nature 1983 306 : 262 4.
13. Baldo BA, Fisher MM. Anaphylaxis to muscle relaxant drugs: cross-reactivity and molecular basis of binding of IgE antibodies detected by radioimmunoassay. Mol Immunol 1983 20 : 1393 400.
14. Baldo BA, Fisher MM. Detection of serum IgE antibodies that react with alcuronium and tubocurarine after life-threatening reactions to muscle relaxant drugs. Anaesth Intens Care 1983 11 : 194 7.
15. Fisher MM, Baldo BA. Adverse reactions to alcuronium. An Australian disease? Med J Aust 1983 1 : 630 2.
16. Harle DG, Baldo BA, Fisher MM. Detection of IgE antibodies to suxamethonium after anaphylactoid reactions during anaesthesia. Lancet 1984 1 : 930 2.
17. Harle DG, Baldo BA, Fisher MM. Assays for, and cross-reactivities of, IgE antibodies to the muscle relaxants gallamine, decamethonium and succinylcholine (suxamethonium). J Immunol Methods 1985 78 : 293 305.
18. Harle DG, Baldo BA, Fisher MM. Cross-reactivity of metocurine, atracurium, vecuronium and fazadinium with IgE antibodies from patients unexposed to these drugs but allergic to other myoneural blocking drugs. Br J Anaesth 1985 57 : 1073 6.
19. Baldo BA, Harle DG. In : Baldo BA, ed. Drug allergenic determinants. Molecular approaches to the study of allergens, Vol. 28. Basel : Karger, 1990 11 51.
20. Baldo BA, Pham NH. Structure-activity studies on drug-induced anaphylactic reactions. Chem Res Toxicol 1994 7 : 703 21.
21. Baldo BA, Pham NH, Zhao Z. Chemistry of drug allergenicity. Curr Opin Allergy Clin Immunol 2001 1 : 327 35.
22. Eisen HN. Hypersensitivity to simple chemicals. In : Lawrence HS, ed. Cellular and humoral aspects of the hypersensitivity states. New York : Hoeber, 1959 89 122.
23. Landsteiner K. The specificity of serological reactions. New York : Dover Publications, 1962.
24. Bundgaard H. Chemical and pharmaceutical aspects of drug allergy. In : de Weck AL, Bundgaard H, eds. Allergic reactions to drugs. Handbook of experimental pharmacology, Vol. 63. Berlin : Springer, 1983 37 74.
25. De Weck AL. Immunopathological mechanisms and clinical aspects of allergic reactions to drugs. In : de Weck AL, Bundgaard H, eds. Allergic reactions to drugs. Handbook of experimental pharmacology, Vol. 63. Berlin : Springer, 1983 75 133.
26. Baldo BA. Immunochemical perspectives of allergy: in the steps of Karl Landsteiner. In : Baldo BA, ed. Molecular approaches to the study of allergens. Monographs in allergy, Vol. 28. Basel : Karger, 1990 1 10.
27. Landsteiner K, Jacobs J. Studies on the sensitization of animals with simple chemical compounds. J Exp Med 1935 61 : 643 57.
28. Parker CW. Drug allergy. In : Parker CW, ed. Clinical immunology, Vol. 2. Philadelphia : Saunders, 1980 1219 60.
29. Skivington MA. Protein binding of muscle relaxants. In : Feldman SA, ed. Major problems in anaesthesia, Vol 1. Muscle relaxants. London : Saunders, 1973 109 16.
30. Thierse H-J, Gamerdinger K, Junkes C, Guerreiro N, Weltzien HU. T cell receptor (TcR) interaction with haptens: metal ions as non-classical haptens. Toxicology 2005 209 : 101 7.
31. Bovet D. Synthetic inhibitors of neuromuscular transmission, chemical structures and structure-activity relationships. In : Cheymol J, ed. Neuromuscular blocking and stimulating agents, Vol 1. International encyclopedia of pharmacology and therapeutics, section 14. Oxford : Pergamon Press, 1972 243 94.
32. Taylor P. Neuromuscular blocking agents. In : Gilman AG, Goodman LS, Gilman A, eds. Goodman and Gilman's the pharmacological basis of therapeutics, 6th edition. New York : Macmillan, 1980 220 34.
33. Vervloet D, Arnaud A, Senft M et al. Anaphylactic reactions to suxamethonium. Prevention of mediator release by choline. J Allergy Clin Immunol 1985 76 : 222 5.
34. Didier A, Cador D, Bongrand P et al. Role of quaternary ammonium ion determinants in allergy to muscle relaxants. J Allergy Clin Immunol 1987 79 : 578 84.
35. Van Regenmortel M. Operational aspects of the definition of epitopes in peptides and proteins. In : Alitalo K, Partanen P, Vaheri A, eds. Synthetic peptides in biology and medicine. Amsterdam : Elsevier, 1985 67 74.
36. Pham NH, Baldo BA, Puy RM. Studies on the mechanism of multiple drug allergies. Structural basis of drug recognition. J Immunoassay Immunochem 2001 22 : 47 73.
37. Harle DG, Baldo BA, Fisher MM. Immunoassays employing substituted ammonium compounds other than neuromuscular blocking drugs to increase the detection of IgE antibodies to these drugs. Mol Immunol 1990 27 : 1039 45.
38. Florvaag E, Johansson SGO, Oman H et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 2005 49 : 437 44.
39. Harle DG. Diagnosis and mechanisms of allergic reactions to anaesthetic drugs. PhD thesis, University of Sydney, 1990.
40. Harle DG, Baldo BA, Fisher MM. The molecular basis of IgE antibody binding to thiopentone. Binding of IgE from thiopentone-allergic and non-allergic subjects. Mol Immunol 1990 27 : 853 8.
41. Baldo BA, Fisher MM. Diagnosis of IgE-dependent anaphylaxis to neuromuscular blocking drugs, thiopentone and opioids. Ann Fr Anesth Reanim 1993 12 : 173 81.
42. Baldo BA, Fisher MM. Mechanisms of IgE-dependent anaphylaxis to anaesthetic drugs. Ann Fr Anesth Reanim 1993 12 : 131 40.
43. Laxenaire MC, Gastin I, Moneret-Vautrin DA, Widmer S, Gueant JL. Cross-reactivity of rocuronium with other neuromuscular blocking agents. Eur J Anaesthesiol 1995 11 (Suppl) : 55 64.
44. Ebo DG, Venemalm L, Bridts CH et al. Immunoglobulin E antibodies to rocuronium. A new diagnostic tool. Anesthesiology 2007 107 : 253 9.
45. Scowen E. Committee on safety of medicine. Brit J Anaesth 1978 50 : 170.
46. Guttormsen AB. Allergic reactions during anaesthesia - increased attention to the problem in Denmark and Norway. Acta Anaesthesiol Scand 2001 45 : 1189 90.
47. Laake JH, Rottingen JA. Rocuronium and anaphylaxis - a statistical challenge. Acta Anaesthesiol Scand 2001 45 : 1196 203.
48. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003 99 : 536 45.
49. Axon AD, Hunter JM. Anaphylaxis and anaesthesia - all clear now? Br J Anaesth 2004 93 : 501 4.
50. Rose M, Fisher MM. Rocuronium: high risk for anaphylaxis? Br J Anaesth 2001 86 : 678 82.
51. Harle DG, Baldo BA, Coroneos NJ, Fisher MM. Anaphylaxis following administration of papaveretum. Case report: implication of IgE antibodies that react with morphine and codeine, and identification of an allergenic determinant. Anesthesiology 1989 71 : 489 94.
52. Fisher MM, Harle DG, Baldo BA. Anaphylactoid reactions to narcotic analgesics. Clin Rev Allergy 1991 9 : 309 18.
53. Fisher MM, Baldo BA. Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs. The value of morphine for the detection of IgE antibodies in allergic subjects. Anaesth Intens Care 2000 28 : 167 70.
54. Florvaag E, Johansson SGO, Oman H, Harboe T, Nopp A. Pholcodine stimulates a dramatic increase of IgE in IgE-sensitized individuals. A pilot study. Allergy 2006 61 : 49 55.
55. Harboe T, Johansson SGO, Florvaag E, Oman H. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents. Allergy 2007 62 : 1445 50.
56. Codreanu F, Morisset M, Kanny G, Moneret-Vautrin DA. Allergy to pholcodine: first case documented by oral challenge. Allergy 2005 60 : 544 5.
57. Johansson SGO, Nopp A, Florvaag E et al. High prevalence of IgE antibodies among blood donors in Sweden and Norway. Allergy 2005 60 : 1312 5.
58. Societe Francaises d'Anesthesie et de Reanimation. Reducing the risk of anaphylaxis during anaesthesia. Ann Fr Anesth Reanim 2002 21 (Suppl 1) : 7s 23s.
59. Association of Anaesthetists of Great Britain and Ireland. Suspected anaphylactic reactions associated with anaesthesia, London, 2003.
60. Kroigaard M, Garvey LH, Gillberg l et al. Scandinavian clinical practice guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia. Acta Anaesthesiol Scand 2007 51 : 655 70.
61. Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989 83 : 1551 5.
62. Yunginger JW, Nelson DR, Squilace DL et al. Laboratory investigation of deaths due to anaphylaxis. J Forensic Sci 1991 36 : 857 65.
63. Enander I, Matsson P, Nystrand J et al. A new radioimmunoassay for human mast cell tryptase using monoclonal antibodies. J Immunol Methods 1991 138 : 39 46.
64. Laroche D, Lefrancois C, Gerard JL et al. Early diagnosis of anaphylactic reactions to neuromuscular blocking drugs. Brit J Anaesth 1992 69 : 611 4.
65. Fisher MM, Baldo BA. Mast cell tryptase in anaesthetic anaphylactoid reactions. Br J Anaesth 1998 80 : 26 9.
66. Harper NJN. Investigating anaesthetic anaphylactic reactions: how, when and where? An overview of anaesthetic allergy services in the UK. Bull R Coll Anaesth 2007 43 : 2173 5.
67. Laxenaire MC, Mertes PM. Anaphylaxis during anaesthesia. Results of a two-year survey in France. Brit J Anaesth 2001 87 : 549 58.
68. Fisher MM, Baldo BA, Silbert BS. Anaphylaxis during anaesthesia: use of radioimmunoassays to determine etiology and drugs responsible in fatal cases. Anesthesiology 1991 75 : 1112 5.
69. Fisher MM, Baldo BA. The diagnosis of fatal anaphylactic reactions during anaesthesia: employment of immunoassays for mast cell tryptase and drug-reactive IgE antibodies. Anaesth Intens Care 1993 21 : 353 7.
70. Ebo DG, Fisher MM, Hagendorens MM, Bridts CH, Stevens WJ. Anaphylaxis during anaesthesia: diagnostic approach. Allergy 2007 62 : 471 87.
71. Baldo BA, Krilis S, Fletcher TC. Phosphorylcholine-containing allergens. Naturwissenschaften 1979 66 : 623 5.
72. Harnett W, Harnett MM. Phosphorylcholine: friend or foe of the immune system? Immunol Today 1999 20 : 125 9.
73. Rose N., Afanasyeva M. Autoimmunity: busting the atherosclerotic plaque. Nat Med 2003 9 : 641 2.
74. Su J, Georgiades A, Wu R, Thulin T, de Faire U, Frostergard J. Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension. Atherosclerosis 2006 188 : 160 6.
75. Marini AM, Matassi G, Raynal V, Andre B, Cartron JP, Cherif-Zahar B. The human rhesus-associated RhAG protein and a kidney homologue promote ammonium transport in yeast. Nat Genet 2000 26 : 341 4.
76. Capron A, Dessaint J-P. A role for IgE in protective immunity. IRCS J Med Sci 1975 3 : 477 81.
77. Heitman J, Agre P. A new face of the rhesus antigen. Nat Genet 2000 26 : 258 9.